TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NCA30963 GMP Mangafodipir

Reagents and contrast media
Scotland (UKM75)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: University Of Edinburgh: "NCA30963 GMP Mangafodipir". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityUniversity Of EdinburghScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: University Of Edinburgh
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for University Of Edinburgh. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
3.3Bids / Report
60.5% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 230 active published awards; 205 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUniversity Of Edinburgh
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published10 Aug 2021, 08:55 BST
Last source update10 Aug 2021, 08:55 BST
Recurring procurementNot published
ClassificationReagents and contrast media
Delivery area
Scotland (UKM75)
OCIDocds-h6vhtk-02d2b4
What is being bought
Formulation and Good Manufacturing Practice preparation of mangafodipir for clinical use in healthy volunteers and patients.
What changed
From the official release history
  1. Status changed to complete
    10 Aug 2021, 08:55 BST
  2. Official notice release published
    10 Aug 2021, 08:55 BST
  3. Buyer information updated
    10 Aug 2021, 08:55 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Under Regulation Reg 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015, a contracting authority may use the negotiated procedure without the prior publication in the case of a public contract, based on the following justification: 2. Competition is absent for technical reasons (only if it is not caused by artificial narrowing down of the parameters of the procurement and no reasonable alternative or substitute exists);
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    10 Aug 2021, 08:55 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 29 Jul 2021, 00:00 BST · US$84,995
Commercial outcome and competition
Awards
Avomeen
Not published · Not published · active
Contracts
Contract
US$84,995 · signed 29 Jul 2021, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
electronicBids: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 1 (lot 1)
smeBids: 0 (lot 1)
Buyer and organisations in this procedure

University Of Edinburgh

Contracting authority GB-FTS-2023
View buyer profile

  • University Of Edinburgh
    buyer

    Charles Stewart House, 9-16 Chambers Street, Edinburgh, UKM75, EH1 1HT
    andrew.helmn@ed.ac.uk
    +44 1316502508

  • Avomeen
    supplier

    4840 Venture Drive, Ann Arbor, US, 48108
    +001 7348646920

  • Edinburgh Sheriff Court & Justice of the Peace Court
    reviewBody

    Edinburgh
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleFor the last 2 years, we have been trying to source further preparations of the mangafodipir. This has included a global search for suppliers which has been unsuccessful. We are working with a Norwegian company to provide the product but has proved unsuccessful although future supplies may be possible in 1-2 years’ time. However, we have ongoing clinical trials and need a supply as soon as possible. We have now engaged with Avomeen (Element) who have previous experience with working with the product: this is quite unique with no other supplier having this experience. The product is rather complex to manufacture and formulate and given that they are the only current provider to generate the product and have the expertise, we have gone back to them. They seem to be the only company able to deal with the complexity of manufacture. The other issue is availability. The world’s supply and capacity for sterile fill products is severely stretched due to the massive global demand for SARS-CoV2 vaccines. We have worked with Element to try alternative sterile fill premises but there is no capacity in other facilities for the immediate future.